Portfolio concentration
As of April 30, 2026 · N-PORT
Holdings
61
Top-10 weight
26.04%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
54
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
414.9
Holdings
As of April 30, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | IMMUNITYBIO INC | — | 401,005 | $2.85M | 4.80% |
| 2 | DREYFUS GOVT CASH MGMT FUND | DGCXX | 1,868,134 | $1.87M | 3.15% |
| 3 | APELLIS PHARMACEUTICALS INC | — | 37,509 | $1.54M | 2.59% |
| 4 | KALVISTA PHARMACEUTICALS INC | — | 55,964 | $1.49M | 2.52% |
| 5 | MODERNA INC | — | 32,122 | $1.48M | 2.49% |
| 6 | IOVANCE BIOTHERAPEUTICS INC | — | 430,167 | $1.45M | 2.44% |
| 7 | MIRUM PHARMACEUTICALS INC | — | 14,558 | $1.42M | 2.39% |
| 8 | AXSOME THERAPEUTICS INC | — | 6,386 | $1.33M | 2.24% |
| 9 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | — | 22,754 | $1.22M | 2.06% |
| 10 | ROIVANT SCIENCES LTD | — | 42,821 | $1.22M | 2.06% |
| 11 | ZAI LAB LTD UNSPNRD ADR | — | 53,256 | $1.15M | 1.94% |
| 12 | LIGAND PHARMACEUTICALS | — | 4,992 | $1.15M | 1.93% |
| 13 | BIOCRYST PHARMACEUTICALS INC | — | 125,015 | $1.15M | 1.93% |
| 14 | TRAVERE THERAPEUTICS INC | — | 27,170 | $1.14M | 1.93% |
| 15 | NOVAVAX INC | — | 144,044 | $1.14M | 1.93% |
| 16 | UNITED THERAPEUTICS CORP DEL | — | 1,914 | $1.09M | 1.84% |
| 17 | GERON CORP | — | 695,861 | $1.07M | 1.81% |
| 18 | BIONTECH SE ADR | — | 9,981 | $1.03M | 1.74% |
| 19 | AMGEN INC | — | 2,977 | $1.03M | 1.74% |
| 20 | EXELIXIS INC | — | 23,148 | $1.03M | 1.74% |
| 21 | BIOGEN INC | — | 5,434 | $1.03M | 1.73% |
| 22 | GILEAD SCIENCES INC | — | 7,859 | $1.03M | 1.73% |
| 23 | TG THERAPEUTICS INC | — | 30,187 | $1.02M | 1.72% |
| 24 | KRYSTAL BIOTECH INC | — | 3,866 | $1.01M | 1.71% |
| 25 | LEGEND BIOTECH CORP SPON ADR | — | 42,398 | $997.20K | 1.68% |
| 26 | SYNDAX PHARMACEUTICALS INC | — | 46,457 | $995.57K | 1.68% |
| 27 | ARROWHEAD PHARMACEUTICALS INC | — | 13,501 | $992.05K | 1.67% |
| 28 | Ascendis Pharma A/S | — | 4,293 | $984.73K | 1.66% |
| 29 | AGIOS PHARMACEUTICALS INC | — | 34,703 | $971.68K | 1.64% |
| 30 | HALOZYME THERAPEUTICS INC | — | 15,211 | $968.33K | 1.63% |
| 31 | ARDELYX INC | — | 152,393 | $964.65K | 1.63% |
| 32 | BIOMARIN PHARMACEUTICAL INC | — | 17,750 | $956.90K | 1.61% |
| 33 | INCYTE CORP | — | 9,918 | $944.89K | 1.59% |
| 34 | AURINIA PHARMS. INC | AUPH US | 59,707 | $918.59K | 1.55% |
| 35 | SAREPTA THERAPEUTICS INC | — | 43,955 | $917.78K | 1.55% |
| 36 | REGENERON PHARMACEUTICALS INC | — | 1,276 | $902.21K | 1.52% |
| 37 | BRIDGEBIO PHARMA INC | — | 12,592 | $895.42K | 1.51% |
| 38 | VERTEX PHARMACEUTICALS INC | — | 2,093 | $894.51K | 1.51% |
| 39 | BEONE MEDICINES LTD ADR | — | 2,965 | $875.48K | 1.48% |
| 40 | IONIS PHARMACEUTICALS INC | — | 11,708 | $875.29K | 1.48% |
| 41 | CRISPR THERAPEUTICS AG | — | 16,695 | $873.82K | 1.47% |
| 42 | THERAVANCE BIOPHARMA INC | — | 52,082 | $871.85K | 1.47% |
| 43 | MADRIGAL PHARMACEUTICALS INC | — | 1,655 | $856.28K | 1.44% |
| 44 | KURA ONCOLOGY INC | — | 92,599 | $817.65K | 1.38% |
| 45 | NEUROCRINE BIOSCIENCES INC | — | 6,192 | $815.30K | 1.38% |
| 46 | PTC THERAPEUTICS INC | — | 12,510 | $813.90K | 1.37% |
| 47 | ACADIA PHARMACEUTICALS INC | — | 34,855 | $782.49K | 1.32% |
| 48 | ARCUTIS BIOTHERAPEUTICS INC | — | 32,610 | $757.20K | 1.28% |
| 49 | TARSUS PHARMACEUTICALS INC | — | 11,632 | $739.91K | 1.25% |
| 50 | ALNYLAM PHARMACEUTICALS INC | — | 2,379 | $736.28K | 1.24% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.